Tag: point-of-care-testing (poct) market forecast

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The point-of-care testing (POCT) market is rapidly evolving as healthcare systems worldwide seek faster, more accessible diagnostic solutions. With technological advances and shifting healthcare delivery models, this sector is poised for significant expansion. Let’s explore the current market size, key growth drivers, segmentation, emerging trends, main competitors, and regional dynamics shaping the POCT industry.

Current Market Size and Projected Growth Trajectory for the POCT Market

The POCT market has witnessed swift development over recent years. Its valuation is projected to rise from $50.79 billion in 2025 to $56.68 billion in 2026, marking a compound annual growth rate (CAGR) of 11.6%. This growth during the historical period results from increasing chronic disease rates, the urgent need for quick clinical decisions, expansion in emergency and critical care services, limited access to centralized labs, and the demand for immediate diagnostic results. Moving forward, the market is expected to surge further, reaching $86.91 billion by 2030, with a CAGR of 11.3%. Factors driving this forecasted growth include ongoing miniaturization of POCT devices, the rise of home care and remote patient monitoring, frequent outbreaks of infectious diseases, decentralization of healthcare, and wider adoption of self-testing diagnostics. Key trends anticipated during this period comprise greater use of rapid diagnostic testing at the point of care, rising consumer preference for home-based and self-testing options, expansion of over-the-counter diagnostic products, increased focus on early disease detection and screening, and improvements in the accuracy and sensitivity of POCT devices.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27391&type=smp

The Role of Telemedicine in Boosting Demand for POCT

One of the strongest drivers of POCT market growth is the expanding adoption of telemedicine services. Telemedicine involves delivering healthcare remotely through digital platforms such as video conferencing, phone calls, or secure messaging. The COVID-19 pandemic accelerated the acceptance of telemedicine by emphasizing the need for convenient, timely, and contactless care options. POCT complements telemedicine by enabling rapid and reliable diagnostic results that can be instantly shared with healthcare providers located remotely. For example, data from the American Hospital Association indicated that in 2023, over 12.6% of Medicare beneficiaries in the US used telehealth services. Moreover, projections show that by 2036, the physician workforce in the country could reach approximately 86,000, with telehealth playing a crucial role in alleviating healthcare provider shortages. This growing reliance on telemedicine is thus a key factor propelling the expansion of the POCT market.

Segments and Structure within the Point-of-Care Testing Market

The POCT market is systematically divided into several main segments:

1) Type of Test: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas or Electrolytes Testing, Urinalysis Testing, and Other Types

2) Mode of Purchase: Over-the-Counter Products and Prescribed Products

3) Technology Utilized: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, and Biochemical Testing

4) End-User Categories: Clinical Laboratories, Ambulatory Care Facilities and Physician Offices, Pharmacies, Retail Clinics and E-Commerce Platforms, Hospitals, Critical Care Centers, Urgent Care Centers, Home Care and Self-Testing, and Other End-Users

Access The Complete Point-Of-Care-Testing (POCT) Market Report:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

Further breakdowns include subcategories such as:

– Blood Glucose Testing: Self-Monitoring Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices

– Infectious Diseases Testing: HIV, Hepatitis, Influenza, COVID-19, and other infections

– Cardiac Markers Testing: Troponin, CK-MB, Myoglobin, BNP tests

– Coagulation Testing: Prothrombin Time, Activated Partial Thromboplastin Time, International Normalized Ratio

– Pregnancy and Fertility Testing: Pregnancy test kits, Ovulation test kits, Fertility hormone tests

– Blood Gas or Electrolytes Testing: Arterial and Venous blood gas tests, Electrolyte tests

– Urinalysis Testing: Urine chemistry analysis, Microscopic examination, Culture testing

– Other Types: Drug abuse, Allergy, Cholesterol, Thyroid function tests

Advancements and Technological Innovations Influencing POCT Growth

Leading players in the POCT market are channeling resources into cutting-edge technologies to meet the increasing desire for faster, clinic-level diagnostics. A prominent example is microfluidic rapid antimicrobial susceptibility testing (AST) systems, which use tiny fluid channels to culture and detect bacteria from patient samples such as urine. These systems can determine antibiotic susceptibility much faster than traditional culture methods that take days to yield results. For instance, in June 2023, Japan-based Sysmex Corporation launched the PA 100 AST System, a compact POCT analyzer that employs proprietary microfluidic cartridges to detect bacteria in roughly 15 minutes and deliver complete antimicrobial susceptibility results in about 30 minutes. This user-friendly device requires minimal training, as healthcare workers simply load the sample into a cartridge and insert it into the analyzer for automated results. The quick turnaround enables timely antibiotic treatment decisions during the initial patient consultation, helping reduce inappropriate prescriptions and combat antimicrobial resistance.

Key Companies Leading the Point-of-Care Testing Market

The POCT market features several prominent companies that shape the competitive landscape. These include Johnson & Johnson, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY, Accriva, ACON Laboratories, Sekisui Diagnostics, PTS Diagnostics, and Meridian Bioscience.

Regional Market Insights and Growth Patterns

In 2025, North America held the largest share of the POCT market. However, the Asia-Pacific region is anticipated to experience the fastest growth throughout the forecast period. The report analyzes various regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a broad perspective on global market trends and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Point-Of-Care-Testing (POCT) Market Expected To Reach Based On Its 2026 Value?

The point-of-care-testing (poct) market size has experienced swift expansion in recent years. It is anticipated to grow from $50.79 billion in 2025 to $56.68 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.6%. The historical growth can be attributed to the rising prevalence of chronic diseases, a heightened requirement for rapid clinical decision-making, the expansion of emergency and critical care services, constrained access to centralized laboratories, and the demand for immediate diagnostic outcomes.

The point-of-care-testing (poct) market size is expected to show significant expansion in the next few years. It is projected to reach $86.91 billion by 2030, with a compound annual growth rate (CAGR) of 11.3%. The expansion anticipated during the forecast period is largely due to advancements in poct device miniaturization, the increasing availability of home care and remote patient monitoring, a rise in infectious disease outbreaks, the ongoing decentralization of healthcare, and the growing acceptance of self-testing diagnostics. Important trends expected in this period include a greater adoption of rapid diagnostic testing at the point of care, an increasing need for home-based and self-testing solutions, the broadening of over-the-counter diagnostic products, an intensified focus on early disease detection and screening, and improvements in the accuracy and sensitivity of poct devices.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

Which Strong Drivers Are Impacting The Point-Of-Care-Testing (POCT) Market Growth?

The expanding use of telemedicine is anticipated to fuel the growth of the point-of-care-testing (POCT) market in the future. Telemedicine involves delivering medical care remotely through digital communication tools such as video and phone calls, or secure messaging. This adoption is driven by an increasing need for convenient, timely, and contact-free healthcare, a demand significantly accelerated by the COVID-19 pandemic. Point-of-care testing (POCT) supports telemedicine by providing quick, dependable diagnostic results that can be immediately shared with distant healthcare providers. For instance, in April 2025, according to the American Hospital Association, a US-based professional organization, over 12.6% of Medicare beneficiaries utilized telehealth services in 2023. By 2036, the number of physicians is projected to reach up to 86,000. Telehealth plays a crucial role in helping to ease the growing physician shortage. As a result, the increasing adoption of telemedicine is propelling the expansion of the point-of-care-testing (POCT) market.

Which Segment Types Are Examined In The Point-Of-Care-Testing (POCT) Market Segment Study?

The point-of-care-testing (poct) market covered in this report is segmented –

1) By Type: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types

2) By Mode Of Purchase: Over-The-Counter Products, Prescribed Based Products

3) By Technology: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing

4) By End-User: Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users

Subsegments:

1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices

2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing

3) By Cardiac Markers Testing: Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing

4) By Coagulation Testing: Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing

5) By Pregnancy And Fertility Testing: Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing

6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing

7) By Urinalysis Testing: Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing

8) By Other Types: Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing

Which Trends Are Contributing To Changes In The Point-Of-Care-Testing (POCT) Market?

Major companies in the point-of-care testing (POCT) market are increasingly prioritizing technological advancements, such as microfluidic rapid antimicrobial-susceptibility testing (AST) systems, to address the growing need for faster, clinic-level diagnostics and improved antimicrobial stewardship in primary care. This microfluidic AST technology leverages fluid channels at the micrometer scale to culture and detect bacteria from patient samples—like urine—and determine their antibiotic susceptibility in a fraction of the time required by conventional culture-based methods, which can take several days. For example, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, introduced the PA 100 AST System, a compact POCT analyser that employs Sysmex Astrego’s proprietary microfluidic cartridges to detect bacteria in approximately 15 minutes and provide complete AST results in about 30 minutes. The system is highly user-friendly: healthcare professionals simply place the sample into a single-use cartridge, insert it into the desktop analyser, and receive automated AST readouts without needing specialized laboratory training. This rapid turnaround allows timely antibiotic decisions during the first patient visit, supporting efforts to reduce inappropriate prescriptions and combat antimicrobial resistance (AMR).

Which Players Are Part Of The Competitive Landscape Of The Point-Of-Care-Testing (POCT) Market?

Major companies operating in the point-of-care-testing (poct) market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY, Accriva, ACON Laboratories, Sekisui Diagnostics, PTS Diagnostics, Meridian Bioscience

Get The Full Point-Of-Care-Testing (POCT) Market Report:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

Which Region Leads The Point-Of-Care-Testing (POCT) Market In Terms Of Market Share?

North America was the largest region in the point-of-care testing (POCT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (poct) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Point-Of-Care-Testing (POCT) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

Browse Through More Reports Similar to the Global Point-Of-Care-Testing (POCT) Market 2026, By The Business Research Company

Precast Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/precast-construction-global-market-report

Modular And Prefabricated Nonresidential Building Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/modular-and-prefabricated-nonresidential-building-construction-global-market-report

Ready Mix Concrete Market Report 2026

https://www.thebusinessresearchcompany.com/report/ready-mix-concrete-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Point-Of-Care-Testing (POCT) Market Evolve From 2026 To 2030?

The point-of-care-testing (poct) market size has demonstrated rapid expansion in recent years. It is forecast to grow from $50.79 billion in 2025 to $56.68 billion in 2026, at a compound annual growth rate (CAGR) of 11.6%. The historical growth can be ascribed to a number of factors, including the increasing prevalence of chronic diseases, the growing necessity for quick clinical decision making, the rise in emergency and critical care services, constrained access to centralized laboratories, and the demand for immediate diagnostic findings.

The point-of-care-testing (poct) market size is anticipated to experience substantial growth over the next few years. It is projected to expand to $86.91 billion in 2030, achieving a compound annual growth rate (CAGR) of 11.3%. This expected expansion during the forecast period can be attributed to advancements in poct device miniaturization, the increased prevalence of home care and remote patient monitoring, a rise in infectious disease outbreaks, the progressive decentralization of healthcare, and the growing adoption of self-testing diagnostics. Significant trends within this period include the increasing implementation of rapid diagnostic testing at the point of care, a higher demand for home-based and self-testing solutions, the proliferation of over-the-counter diagnostic products, a strengthened emphasis on early disease detection and screening, and improvements in the accuracy and sensitivity of poct devices.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27391&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Point-Of-Care-Testing (POCT) Market?

The expanding utilization of telemedicine is set to propel the growth of the point-of-care-testing (POCT) market going forward. Telemedicine refers to the provision of medical care remotely, employing digital communication technologies such as video calls, phone calls, or secure messaging. The uptake of telemedicine is driven by increasing demand for convenient, timely, and contact-free healthcare services, notably boosted by the COVID-19 pandemic. Point-of-care testing (POCT) supports telemedicine by offering rapid, reliable diagnostic results that can be instantly shared with remote healthcare providers. For instance, in April 2025, data from the American Hospital Association, a US-based professional organization company, showed that in 2023, more than 12.6% of Medicare beneficiaries used telehealth services. By 2036, the number of physicians is projected to reach up to 86,000. Telehealth plays a vital role in helping to alleviate the growing physician shortage. Therefore, the increasing adoption of telemedicine is driving the expansion of the point-of-care-testing (POCT) market.

Which Segment Areas Are Covered In The Point-Of-Care-Testing (POCT) Market Analysis?

The point-of-care-testing (poct) market covered in this report is segmented –

1) By Type: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types

2) By Mode Of Purchase: Over-The-Counter Products, Prescribed Based Products

3) By Technology: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing

4) By End-User: Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users

Subsegments:

1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices

2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing

3) By Cardiac Markers Testing: Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing

4) By Coagulation Testing: Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing

5) By Pregnancy And Fertility Testing: Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing

6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing

7) By Urinalysis Testing: Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing

8) By Other Types: Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing

What Key Developments And Trends Are Impacting The Point-Of-Care-Testing (POCT) Market?

Leading companies in the point-of-care testing (POCT) market are increasingly emphasizing technological innovations, such as microfluidic rapid antimicrobial-susceptibility testing (AST) systems, to meet the growing demand for quicker, clinic-level diagnostics and improved antimicrobial stewardship in primary care. This microfluidic AST technology utilizes fluid channels at the micrometer scale to culture and identify bacteria from patient samples—like urine—and determine their antibiotic susceptibility in a fraction of the time required by conventional culture-based methods, which can take several days. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, unveiled the PA 100 AST System, a compact POCT analyser that employs Sysmex Astrego’s proprietary microfluidic cartridges to detect bacteria in approximately 15 minutes and deliver complete AST results in about 30 minutes. The system is exceptionally user-friendly: healthcare professionals simply place the sample into a single-use cartridge, insert it into the desktop analyser, and receive automated AST readouts without needing specialized laboratory training. This quick turnaround enables timely antibiotic decisions during the initial patient visit, supporting efforts to reduce inappropriate prescriptions and combat antimicrobial resistance (AMR).

Which Global Companies Are Actively Competing In The Point-Of-Care-Testing (POCT) Market?

Major companies operating in the point-of-care-testing (poct) market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY, Accriva, ACON Laboratories, Sekisui Diagnostics, PTS Diagnostics, Meridian Bioscience

Read the full point-of-care-testing (poct) market report here:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

What Are The Leading Geographic Regions In The Point-Of-Care-Testing (POCT) Market?

North America was the largest region in the point-of-care testing (POCT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (poct) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Point-Of-Care-Testing (POCT) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27391&type=smp

Browse Through More Reports Similar to the Global Point-Of-Care-Testing (POCT) Market 2026, By The Business Research Company

Precast Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/precast-construction-global-market-report

Modular And Prefabricated Nonresidential Building Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/modular-and-prefabricated-nonresidential-building-construction-global-market-report

Ready Mix Concrete Market Report 2026

https://www.thebusinessresearchcompany.com/report/ready-mix-concrete-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Point-Of-Care-Testing (POCT) Market in 2026, and what figure is it projected to hit by 2030?

The point-of-care-testing (poct) market has experienced swift expansion over recent years. Forecasts indicate it will increase from $50.79 billion in 2025 to $56.68 billion by 2026, achieving a compound annual growth rate (CAGR) of 11.6%. The historical expansion of this market stems from several factors, including the escalating prevalence of chronic diseases, a growing necessity for rapid clinical decision-making, the development of emergency and critical care services, limited access to centralized laboratories, and the demand for immediate diagnostic results.

The market for point-of-care-testing (poct) is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $86.91 billion by 2030, demonstrating an 11.3% compound annual growth rate (CAGR). Factors driving this growth during the projection period include advancements in poct device miniaturization, the increase in home care and remote patient monitoring services, the proliferation of infectious disease outbreaks, the decentralization of healthcare, and the increasing uptake of self-testing diagnostics. Key trends anticipated for this forecast span include the increasing use of rapid diagnostic testing at the point of care, heightened demand for home-based and self-testing solutions, the broadening availability of over-the-counter diagnostic products, a greater emphasis on early disease detection and screening, and enhancements in the accuracy and sensitivity of poct devices.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27391&type=smp

Which Drivers Are Affecting Market Participation In The Point-Of-Care-Testing (POCT) Market?

The future expansion of the point-of-care-testing (POCT) market is anticipated to be fueled by the rising integration of telemedicine. Telemedicine involves providing healthcare services from a distance, leveraging digital communication tools like video calls, phone calls, or encrypted messages. The increased uptake of telemedicine stems from a growing need for accessible, prompt, and touchless healthcare, a trend significantly hastened by the COVID-19 pandemic. Point-of-care testing (POCT) complements telemedicine by delivering swift and dependable diagnostic data, which can be shared immediately with medical professionals located remotely. As an illustration, in April 2025, data from the American Hospital Association, a professional organization company in the US, indicated that over 12.6% of Medicare beneficiaries used telehealth services in 2023. Projections show that by 2036, the physician count will rise to 86,000. Telehealth is crucial in addressing the growing scarcity of physicians. Consequently, the expanding use of telemedicine is propelling the point-of-care-testing (POCT) market forward.

What Segment Categories Are Covered In The Point-Of-Care-Testing (POCT) Market?

The point-of-care-testing (poct) market covered in this report is segmented –

1) By Type: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types

2) By Mode Of Purchase: Over-The-Counter Products, Prescribed Based Products

3) By Technology: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing

4) By End-User: Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users

Subsegments:

1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices

2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing

3) By Cardiac Markers Testing: Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing

4) By Coagulation Testing: Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing

5) By Pregnancy And Fertility Testing: Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing

6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing

7) By Urinalysis Testing: Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing

8) By Other Types: Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing

Which Trends Are Influencing The Development Of The Point-Of-Care-Testing (POCT) Market?

Leading entities within the point-of-care testing (POCT) market are increasingly prioritizing technological advancements, notably microfluidic rapid antimicrobial-susceptibility testing (AST) systems, in response to the rising demand for quicker, clinic-based diagnostics and enhanced antimicrobial management in primary healthcare settings. This microfluidic AST technology utilizes fluid pathways at the micrometer dimension to cultivate and identify bacteria in patient specimens, like urine, and ascertain their antibiotic susceptibility significantly faster than traditional culture-based approaches, which often span multiple days. As an illustration, in June 2023, Sysmex Corporation, a Japanese diagnostics firm, launched the PA 100 AST System. This compact POCT analyzer integrates Sysmex Astrego’s exclusive microfluidic cartridges to identify bacteria in roughly 15 minutes and deliver full AST outcomes within approximately 30 minutes. The system boasts significant ease of use: medical practitioners merely place the sample into a disposable cartridge, insert it into the desktop analyzer, and obtain automated AST reports without requiring specialized lab expertise. This swift processing enables prompt antibiotic choices during the initial patient consultation, thereby aiding initiatives to decrease unsuitable prescriptions and counteract antimicrobial resistance (AMR).

Which Key Market Players Are Investing In Expansion And Innovation Within The Point-Of-Care-Testing (POCT) Market?

Major companies operating in the point-of-care-testing (poct) market are Johnson & Johnson, F. Hoffmann‑La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY, Accriva, ACON Laboratories, Sekisui Diagnostics, PTS Diagnostics, Meridian Bioscience

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

Which Regions Are Projected To Dominate The Point-Of-Care-Testing (POCT) Market In The Coming Years?

North America was the largest region in the point-of-care testing (POCT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (poct) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Point-Of-Care-Testing (POCT) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27391&type=smp

Browse Through More Reports Similar to the Global Point-Of-Care-Testing (POCT) Market 2026, By The Business Research Company

Precast Construction Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/precast-construction-global-market-report

Modular And Prefabricated Nonresidential Building Construction Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/modular-and-prefabricated-nonresidential-building-construction-global-market-report

Ready Mix Concrete Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ready-mix-concrete-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the point-of-care-testing (poct) market from 2025–2034 with trusted insights from The Business Research Company

How Is The Point-Of-Care-Testing (POCT) Market Expected To Grow In Terms Of Size?

The point-of-care-testing (POCT) market size has experienced swift expansion in recent years. It is anticipated to increase from $45.45 billion in 2024 to $50.79 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.8%. The reasons for this growth in previous periods include a heightened emphasis on personalized medicine, increased financial commitments to healthcare infrastructure, a rise in urgent care incidents, the expanding utilization of point-of-care molecular testing, and the growing incorporation of artificial intelligence in diagnostic methods.

The market for point-of-care-testing (POCT) is projected to experience swift expansion over the coming years. This market is anticipated to reach $78.19 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.4%. Factors contributing to this growth during the projection period include a heightened demand for personalized medicine, the expansion of telehealth and remote monitoring practices, improved access to healthcare in developing regions, the broader utilization of POCT in unconventional environments, and the increasing uptake of wearable diagnostic tools. Key trends foreseen in the forecast timeframe encompass improvements in multiplex testing platforms, the creation of portable molecular diagnostic equipment, breakthroughs in smartphone-dependent diagnostic instruments, progress in connectivity and data integration, and the formulation of AI-driven POCT remedies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27391&type=smp

What Market Forces Are Contributing To The Growth Of The Point-Of-Care-Testing (POCT) Market?

The point-of-care-testing (POCT) market is projected to expand due to the rising integration of telemedicine. Telemedicine involves providing healthcare services from a distance, utilizing digital communication tools like video conferencing, telephone calls, or secure messaging platforms. Its widespread use stems from the growing need for accessible, prompt, and touchless medical consultations, a trend significantly bolstered by the COVID-19 pandemic. Point-of-care testing (POCT) complements telemedicine by delivering swift and dependable diagnostic outcomes that can be immediately transmitted to distant medical professionals. An illustrative example comes from February 2023: a survey conducted between July 12 and August 22, 2022, by Rock Health, a US-based health technology company, involved 8,014 respondents. The findings showed that 76% of individuals aged over 55 had utilized telemedicine, and 80% of all participants indicated they had accessed care through telemedicine at some point, marking an 8% increase from 72% in 2021. Consequently, the expanding use of telemedicine is fueling the expansion of the point-of-care-testing (POCT) market.

How Is The Point-Of-Care-Testing (POCT) Market Segmented Across Key Categories?

The point-of-care-testing (POCT) market covered in this report is segmented

1) By Type: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types

2) By Mode Of Purchase: Over-The-Counter Products, Prescribed Based Products

3) By Technology: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing

4) By End-User: Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users

Subsegments:

1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices

2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing

3) By Cardiac Markers Testing: Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing

4) By Coagulation Testing: Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing

5) By Pregnancy And Fertility Testing: Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing

6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing

7) By Urinalysis Testing: Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing

8) By Other Types: Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing

What Key Trends Are Driving Growth In The Point-Of-Care-Testing (POCT) Market?

Leading firms within the point-of-care-testing (POCT) market are concentrating their efforts on creating novel products, like blood glucose management solutions, aimed at enhancing diagnostic speed, precision, and patient results in close proximity to patients. These blood glucose management solutions encompass instruments, devices, and systems employed for monitoring, tracing, and regulating blood sugar levels to manage conditions like diabetes. An example is the launch of the Cobas pulse system in January 2022 by F. Hoffmann-La Roche AG, a pharmaceutical company based in Switzerland. The Cobas pulse system presents an advanced connected platform, integrating sophisticated point-of-care blood glucose testing with the functionalities of smart devices. This system facilitates smooth integration with hospital information technology (IT) systems, allowing for automated result transfers and immediate access to clinical data. Furthermore, the device supports healthcare applications, which improve decision-making assistance and operational efficiency directly with the patient.

Who Are The Major Stakeholders Operating In The Point-Of-Care-Testing (POCT) Market?

Major companies operating in the point-of-care-testing (POCT) market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Zoetis Inc., BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, SiPhox Inc., and Sinocare Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

How Do Regional Dynamics Influence The Point-Of-Care-Testing (POCT) Market Performance?

North America was the largest region in the point-of-care testing (POCT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (POCT) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27391&type=smp

Browse Through More Reports Similar to the Global Point-Of-Care-Testing (POCT) Market 2025, By The Business Research Company

Precast Concrete Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Modular And Prefabricated Nonresidential Building Construction Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/modular-and-prefabricated-nonresidential-building-construction-global-market-report

Ready Mix Concrete Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ready-mix-concrete-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Point-Of-Care-Testing (POCT) Market From 2025 To 2034?

The point-of-care-testing (POCT) market has experienced rapid expansion in recent years. Its valuation is set to climb from $45.45 billion in 2024 to $50.79 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 11.8%. This historical growth can be ascribed to a heightened focus on personalized medicine, escalating investments within healthcare infrastructure, an increase in emergency care situations, the expanded utilization of point-of-care molecular testing, and the rising integration of AI in diagnostic processes.

The point-of-care-testing (POCT) market is anticipated to experience significant growth in the coming years. It is projected to expand to $78.19 billion by 2029, achieving a compound annual growth rate (CAGR) of 11.4%. The expansion during the forecast period can be attributed to factors such as increasing demand for personalized medicine, the rise of telehealth and remote monitoring trends, improved healthcare access in developing markets, the expanding application of POCT in non-traditional environments, and the rising adoption of wearable diagnostic devices. Key trends for the forecast period involve advancements in multiplex testing platforms, the creation of portable molecular diagnostic devices, innovations in smartphone-based diagnostic tools, progress in connectivity and data integration, and the development of AI-powered POCT solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27391&type=smp

What Are The Key Drivers Of Growth In The Point-Of-Care-Testing (POCT) Market?

The expanding use of telemedicine is projected to fuel the growth of the point-of-care-testing (POCT) market moving forward. Telemedicine involves providing medical care remotely through digital communication platforms like video calls, phone conversations, or secure messaging. Its uptake stems from an increasing need for accessible, prompt, and contact-free healthcare, a demand significantly boosted by the COVID-19 pandemic. Point-of-care testing (POCT) complements telemedicine by delivering swift, accurate diagnostic outcomes that can be instantly shared with remote healthcare professionals. As an illustration, a survey conducted by Rock Health, a US-based health technology company, among 8,014 respondents from July 12 to August 22, 2022, revealed in February 2023 that 76% of individuals aged over 55 had utilized telemedicine. Furthermore, 80% of all respondents indicated having accessed care via telemedicine at some point, representing an 8% increase from 72% in 2021. Consequently, the growing integration of telemedicine is a key factor propelling the expansion of the point-of-care-testing (POCT) market.

What Are The Leading Segments Analyzed In The Point-Of-Care-Testing (POCT) Market?

The point-of-care-testing (POCT) market covered in this report is segmented

1) By Type: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types

2) By Mode Of Purchase: Over-The-Counter Products, Prescribed Based Products

3) By Technology: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing

4) By End-User: Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users

Subsegments:

1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices

2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing

3) By Cardiac Markers Testing: Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing

4) By Coagulation Testing: Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing

5) By Pregnancy And Fertility Testing: Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing

6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing

7) By Urinalysis Testing: Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing

8) By Other Types: Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing

What Are The Major Trends Driving The Growth Of The Point-Of-Care-Testing (POCT) Market?

Leading companies in the point-of-care-testing (POCT) market are concentrating on creating innovative products, such as blood glucose management solutions, to enhance diagnostic speed, accuracy, and patient results in near-patient environments. Blood glucose management solutions denote the instruments, apparatuses, and systems utilized for monitoring, tracking, and regulating blood sugar levels to manage conditions like diabetes. For example, in January 2022, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, introduced the Cobas pulse system. The Cobas pulse system presents a next-generation connected platform that merges advanced point-of-care blood glucose testing with smart device functionalities. It allows for effortless integration with hospital information technology (IT) systems for automatic result transmission and real-time clinical data availability. The device also supports healthcare applications to improve decision support and operational efficiency at the patient’s side.

Who Are The Key Multinational Companies Dominating The Point-Of-Care-Testing (POCT) Market?

Major companies operating in the point-of-care-testing (POCT) market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Zoetis Inc., BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, SiPhox Inc., and Sinocare Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

What Are The Regional Market Dynamics Impacting The Point-Of-Care-Testing (POCT) Industry?

North America was the largest region in the point-of-care testing (POCT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (POCT) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Point-Of-Care-Testing (POCT) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27391&type=smp

Browse Through More Reports Similar to the Global Point-Of-Care-Testing (POCT) Market 2025, By The Business Research Company

Precast Concrete Market 2025

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Precast Construction Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/precast-construction-global-market-report

Modular And Prefabricated Nonresidential Building Construction Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/modular-and-prefabricated-nonresidential-building-construction-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Point-Of-Care-Testing (POCT) Industry?

In recent times, there has been a significant expansion in the point-of-care-testing (POCT) market. The market is projected to swell from $45.45 billion in 2024 to about $50.79 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. The expansion of the market during the historical period is due to the growing emphasis on personalized medicine, escalating investments in healthcare infrastructure, an increase in emergency care instances, a surging application of point-of-care molecular testing, and the escalating integration of AI in diagnostics.

Anticipated speedy expansion in the upcoming years is predicted for the point-of-care-testing (POCT) market, with projections placing its value at $78.19 billion by 2029, yielding a compound annual growth rate (CAGR) of 11.4%. This projected growth could be fueled by various factors such as a mounting demand for individualized healthcare, increasingly prevalent telehealth and remote monitoring, improved healthcare availability in developing markets, wider application in non-standard environments, and ascending popularity of wearable diagnostic tools. Notable trends forecasted for this period include advancements in multiplex testing platforms, the creation of portable molecular diagnostic devices, innovation in smartphone-dependent diagnostic instruments, progress in data connectivity and integration, and the emergence of AI-driven POCT solutions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27391&type=smp

What Forces Are Driving The Growth Of The Point-Of-Care-Testing (POCT) Industry?

The escalated uptake of telemedicine is anticipated to spur the expansion of the point-of-care-testing (POCT) market. Telemedicine pertains to the act of providing healthcare services remotely, utilizing digital communication technologies like video calls, phone calls, or secure messages. Telemedicine’s popularity is on the rise due to the growing need for accessible, quick, and contactless medical services, significantly sped up by the COVID-19 outbreak. Point-of-care testing (POCT) aids telemedicine by offering swift, trustworthy diagnostic outcomes that can be instantly communicated with remote health service providers. For example, a Rock Health survey in February 2023, involving 8,014 participants from July 12 to August 22, 2022, revealed that 76% of individuals above 55 years have utilized telemedicine, and 80% of all surveyed individuals admitted to accessing care through telemedicine at least once in their lives, an increase of 8% from 72% in 2021. Therefore, the skyrocketing uptake of telemedicine is propelling the point-of-care-testing (POCT) market’s growth.

What Is The Overview Of Market Segmentation In The Point-Of-Care-Testing (POCT) Industry?

The point-of-care-testing (POCT) market covered in this report is segmented

1) By Type: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types

2) By Mode Of Purchase: Over-The-Counter Products, Prescribed Based Products

3) By Technology: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing

4) By End-User: Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users

Subsegments:

1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices

2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing

3) By Cardiac Markers Testing: Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing

4) By Coagulation Testing: Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing

5) By Pregnancy And Fertility Testing: Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing

6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing

7) By Urinalysis Testing: Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing

8) By Other Types: Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing

What Future Market Trends Are Projected For The Point-Of-Care-Testing (POCT) Industry?

Leading businesses in the point-of-care-testing (POCT) industry are concentrating on introducing unique products like blood glucose control solutions to enhance diagnostic precision, swiftness, and patient outcomes in near-patient contexts. Blood glucose control solutions encompass systems, devices, and tools that monitor, manage, and adjust blood sugar levels to treat conditions such as diabetes. For example, F. Hoffmann-La Roche AG, a pharmaceutical organization based in Switzerland, introduced the Cobas pulse system in January 2022. This system is a revolutionary combined platform that merges cutting-edge point-of-care blood glucose tests with smart device capabilities. It seamlessly links with hospital IT systems for automatic result transmission and immediate clinical data access. This device incorporates healthcare apps to improve decision-making support and streamline workflow right at the patient’s bedside.

Who Are The Primary Players Operating Across The Global Point-Of-Care-Testing (POCT) Market?

Major companies operating in the point-of-care-testing (POCT) market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Zoetis Inc., BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, SiPhox Inc., and Sinocare Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

Which Region Offers The Most Growth Potential For The Point-Of-Care-Testing (POCT) Market Through 2029?

North America was the largest region in the point-of-care testing (POCT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (POCT) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=27391&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model